Rezdiffra

resmetirom

Approval

ApplicationNDA 217785
Approval dateMar 14, 2024
Approval year2024
SponsorMadrigal

FDA-approved use

To treat noncirrhotic non-alcoholic steatohepatitis with moderate to advanced liver scarring

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Rezdiffra: